Associate Professor, Internal Medicine, University of Texas Medical School, Houston
Gastroenterology
Dr. Sushovan Guha, MD
|
|
Give Review
Sushovan Guha is an expert in the field of Gastroenterology. He went to University of Illinois College of Medicine at Chicago. University of Illinois College of Medicine at Chicago is ranked 49 in research and 85 in primary care medicine Doctor Sushovan Guha, MD is a published physician as well. He has 24 publications published. The latest was: Paraneoplastic thrombocytosis independently predicts poor prognosis in patients with locally advanced pancreatic cancer. Sushovan Guha accepts Medicare payments and is registered with Medicare.gov.
Publications
- Paraneoplastic thrombocytosis independently predicts poor prognosis in patients with locally advanced pancreatic Cancer.
- Reduced incidence and mortality from Colorectal cancer with flexible-sigmoidoscopy screening: a meta-analysis.
- Zerumbone increases oxidative stress in a thiol-dependent ROS-independent manner to increase DNA damage and sensitize Colorectal cancer cells to radiation.
- Bionanoparticles as candidate reference materials for mobility analysis of nanoparticles.
- High rate of Disease-related copy number variations in childhood onset schizophrenia.
- GastroIntestinal Bleeding Due to Pancreatic Arteriovenous Malformation.
- ZIP4 confers resistance to zinc deficiency-induced apoptosis in pancreatic Cancer.
- Diagnostic yield of endoscopic retrograde cholangiopancreatography-based cytology for distinguishing malignant and Benign intraductal papillary mucinous neoplasm: Syst...
- MUC4-mediated regulation of acute phase protein lipocalin 2 through HER2/AKT/NF-κB signaling in pancreatic Cancer.
- Targeting pancreatic Cancer with magneto-fluorescent theranostic gold nanoshells.
- Colonoscopy and Colorectal cancer incidence and mortality.
- Oral Bisphosphonates and Colorectal Cancer: Cumulative Dose and Duration of Use Are Important Predictors of Effect.
- Pancreatic Cancer Screening: What We Do and Do Not Know.
- Reduced risk of colorectal cancer with use of oral bisphosphonates: a Systematic review and meta-analysis.
- Zyflamend suppresses growth and sensitizes human pancreatic tumors to gemcitabine in an orthotopic mouse model through modulation of multiple targets.
- Ursolic Acid Inhibits Growth and Metastasis of Human Colorectal Cancer in an Orthotopic Nude Mouse Model by Targeting Multiple Cell Signaling Pathways: Chemosensitizat...
- Boswellic acid inhibits growth and metastasis of human Colorectal cancer in orthotopic mouse model by downregulating inflammatory, proliferative, invasive and angiogen...
- Epidermal growth factor down-regulates the expression of neutrophil gelatinase-associated lipocalin (NGAL) through E-cadherin in pancreatic Cancer cells.
- Induction of MUC5AC mucin by conjugated bile acids in the Esophagus involves the phosphatidylinositol 3-kinase/protein kinase C/activator protein-1 pathway.
- Frequent loss of heterozygosity of chromosome 1q in Esophageal adenocarcinoma: loss of chromosome 1q21.3 is associated with shorter overall survival.
- Modification of the cysteine residues in IkappaBalpha kinase and NF-kappaB (p65) by xanthohumol leads to suppression of NF-kappaB-regulated gene products and potentiat...
- Circulating microRNAs in Pancreatic Juice as Candidate Biomarkers of Pancreatic Cancer.
- Diagnostic yield of EUS-FNA-based cytology distinguishing malignant and Benign IPMNs: A systematic review and meta-analysis.
Schools
Columbia University
UCLA
Albert Einstein College Med
UCLA Med Center
University Of California Los Angeles
Procedures Preformed
- Colonoscopy, Proctosigmoidoscopy, and Sigmoidoscopy
- Endoscopy (Esophagus, Stomach, Small Intestine)
- Manometry
Conditions Treated
- Abdominal Pain
- Anemia
- Barrett's Esophagus
- Benign Neoplasm of the Digestive System
- View All
Doctors Specialties
- Gastroenterology
Accepted Insurances
Education
-
UCLA -
UCLA Medical Center -
Albert Einstein College of Medicine -
Columbia University -
University of Illinois College of Medicine at Chicago -
Jawaharlal Institute of Postgraduate Medical Education and Research
Hospital
-
University of Texas M.D. Anderson Cancer Center
Drug Facts
| NPI NUMBER | 1538269840 | |
| NPPES Provider LastName | GUHA | |
| NPPES Provider FirstName | SUSHOVAN | |
| NPPES Provider ZIPCode | 770304009 | |
| NPPES Provider State | TX | |
| Specialty Description | Gastroenterology | |
| Total Claim Count | 86.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1538269840 |
| Last Name Of The Provider | GUHA |
| First Name Of The Provider | SUSHOVAN |
| View All |
Similar Doctors
|
Dr. Isaac L. Raijman, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
Dr. Ira L. Flax, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Karen L. Woods, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Alan P. Glombicki, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Paul M. Mauk, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Michael W. Stavinoha, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Melvin K. Lau, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Sreelatha Reddy, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Yasser H. Shaib, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Snehal S. Desai, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael Gagliardi, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Maryam Seyedain, MD |